Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
In some embodiments, the ratio of long-chain triglycerides to medium-chain triglycerides is about 95.0:5.0
Regulatory and compounding status All four compounds share a broadly similar regulatory landscape in the United States as of 2026: None are FDA-approved as finished drug products for therapeutic use All are classified as WADA S2 prohibited substances year-round All four have 503A compounding status of Under Review, meaning the FDA Pharmacy Compounding Advisory Committee (PCAC) has nominated them for evaluation but final category assignments (Category 1 permitted for compounding
OCD+MDD, (OCD patient group with MDD comorbidity)
Magnesium : Required for over 300 enzymatic reactions, including many involved in detoxification
US$ 25.33
US$ 26.79
US$ 23.79
US$ 26.37
US$ 27.75
US$ 25.68
US$ 21.66
